Key result
Combined elevation of RCII and TyG-BMI linked to ~47% higher cardio-cerebrovascular disease risk.
Why the study?
Does the combined elevation of residual cholesterol inflammatory index (RCII) and triglyceride-glucose-body mass index (TyG-BMI) increase the risk of cardio-cerebrovascular disease?
Cohort (n=7,677)
Does the combined elevation of residual cholesterol inflammatory index (RCII) and triglyceride-glucose-body mass index (TyG-BMI) increase the risk of cardio-cerebrovascular disease?
Answers are grounded in this paper and cite their sources.
Combined assessment of the residual cholesterol inflammatory index and TyG-BMI may better identify individuals at high risk for cardio-cerebrovascular disease.
This study aimed to analyze the impact of the residual cholesterol inflammatory index (RCII) and the triglyceride-glucose-body mass index (TyG-BMI) on the risk of cardio-cerebrovascular disease (CCVD). Data were obtained from the China Health and Retirement Longitudinal Study, and participants were categorized into 4 groups based on optimal cutoff values of RCII and TyG-BMI. The influence of RCII, TyG-BMI, and their combination on CCVD was assessed using Cox proportional hazards regression and Kaplan-Meier survival models. A total of 7677 individuals were included. Both higher RCII and higher TyG-BMI were independently associated with increased risk of CCVD. Importantly, the combined elevation of RCII and TyG-BMI showed the highest risk (HR = 1.47, 95% CI = 1.21-1.78, P < .05), whereas elevation of either marker alone was not statistically significant. Furthermore, no significant multiplicative or additive interaction between RCII and TyG-BMI was observed. These findings suggest that combined assessment of RCII and TyG-BMI may better identify high-risk individuals, although the lack of interaction indicates that the 2 indices contribute independently to CCVD risk.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) conducted a cohort in Cardio-cerebrovascular disease (n=7,677). Combined elevation of residual cholesterol inflammatory index (RCII) and triglyceride-glucose-body mass index (TyG-BMI) vs. Lower levels of RCII and TyG-BMI was evaluated on Cardio-cerebrovascular disease (CCVD) (HR 1.47, 95% CI 1.21-1.78, p=<.05). Combined elevation of residual cholesterol inflammatory index and TyG-BMI was associated with the highest risk of cardio-cerebrovascular disease (HR 1.47; 95% CI 1.21-1.78; P<.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: